Trial | NCT00326352  Report issue

Official Title

Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Terminated

  • Study Participants

    40
For reduction of dislocated shoulder, sedation with propofol and remifentanil should give satisfactory operating conditions and pain relief, and significantly reduce the time to full recovery, compared with morphine and midazolam
Propofol is a recognised agent for sedation and remifentanil is a short acting opioid analgesic. We intend to provide sedation with propofol, 0.5 mg/Kg, and analgesia with remifentanil 0.5 microgram/Kg for reduction of dislocated shoulders. This will be a randomised sex-stratified comparison with current therapy which is midazolam incrementally up to a maximum of 0.15 mg/Kg, and morphine incrementally up to 0.15 mg/Kg. The primary outcome measure is time to full recovery. Secondary aspects are pain or discomfort during the procedure and operating conditions.
Study Started
Jul 31
2003
Study Completion
Jun 30
2005
Last Update
May 16
2006
Estimate

Drug Sedation with propofol and remifentanil

Criteria 

Inclusion Criteria:

- Anterior dislocation of the shoulder suitable for manual reduction

Exclusion Criteria:

significant other illness
body weight 25% greater than expected
fear of oxygen masks
alcohol intoxication
No Results Posted